Trexquant Investment’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,454
| Closed | -$171K | – | 1899 |
|
|
2025
Q1 | $171K | Sell |
15,454
-157,097
| -91% | -$1.74M | ﹤0.01% | 1482 |
|
|
2024
Q4 | $1.84M | Sell |
172,551
-99,119
| -36% | -$1.06M | 0.02% | 890 |
|
|
2024
Q3 | $3.45M | Buy |
271,670
+190,961
| +237% | +$2.43M | 0.04% | 616 |
|
|
2024
Q2 | $1.35M | Buy |
+80,709
| New | +$1.35M | 0.02% | 894 |
|
|
2023
Q3 | – | Sell |
-14,763
| Closed | -$153K | – | 1845 |
|
|
2023
Q2 | $153K | Buy |
+14,763
| New | +$153K | ﹤0.01% | 1349 |
|
|
2022
Q3 | – | Sell |
-30,407
| Closed | -$249K | – | 1855 |
|
|
2022
Q2 | $249K | Buy |
30,407
+12,211
| +67% | +$100K | 0.01% | 1223 |
|
|
2022
Q1 | $158K | Buy |
+18,196
| New | +$158K | 0.01% | 1239 |
|
|
2021
Q1 | – | Sell |
-15,812
| Closed | -$285K | – | 1485 |
|
|
2020
Q4 | $285K | Buy |
+15,812
| New | +$285K | 0.03% | 712 |
|